Genre
- Journal Article
The hypothesis that H-ras transformed cells contain alterations in signalling pathways important in controlling the expression of S-adenosylmethionine decarboxylase, (SAMDC) a highly regulated activity in the biosynthesis of polyamines was tested. Mouse 10 T1/2 fibroblasts and H-ras transformed cell lines of varying degrees of malignant potential were treated with agents which affect cAMP levels within cells. Elevations in SAMDC expression were noted in H-ras transformed metastatic C3 cells, which were not observed in either parental, nontransformed III T1/2 fibroblast cells? or in ras transformed NR3 cells, which are only capable of benign tumour formation. Forskolin, a stimulator of cAMP synthesis, was able to increase SAMDC enzyme activity but the response which occurred was dependent upon the cellular phenotype expressed. Actinomycin D pre-treatment of C3 cells prior to exposure to forskolin did not abrogate the elevation observed in SAMDC gene expression suggesting that this was not a transcriptional process mediated event. Forskolin pre-treatment of C3 eel Is did result in a marked increase in the hair-life of SAMDC mRNA transcripts suggesting a role for post-transcriptional stabilization. Furthermore, cycloheximide treatment of malignant C3 cells resulted in elevated SAMDC mRNA levels. Treatment of malignant C3 cells with both cycloheximide and forskolin together resulted in a further additive elevation in SAMDC message levels. Cycloheximide treatment alone was found to affect the half-life of SAMDC mRNA through a mechanism of post-transcriptional stabilization. Additionally, altered SAMDC gene expression in C3 cells which occurred in response to cAMP alterations, was enhanced by stimulation of a protein kinase C pathway suggesting possible interactions between protein kinase C- and cAMP-mediated pathways which affect the regulation of SAMDC expression in highly malignant C3 cells. These results demonstrate aberrant regulation of signalling pathways involved in controlling SAMDC gene expression in H-ras transformed cells capable of malignant progression and provide further insight into the altered growth regulatory program associated with H-ras mediated cellular transformation and malignant progression. (C) 2001 Wiley-Liss, Inc.
St Michaels Hosp 1 001, Dept Lab Med & Pathobiol, Toronto, ON M5B 1A6, Canada. Univ Toronto, Toronto, ON M5B 1A6, Canada.; Hurta, RAR, St Michaels Hosp 1 001, Dept Lab Med & Pathobiol, East Annex,38 Shuter St, Toronto, ON M5B 1A6, Canada.
NEW YORK; DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
WILEY-LISS
PT: J; CR: AMARA FM, 1995, CANCER RES, V55, P4503 AUVINEN M, 1992, NATURE, V360, P355 AUVINEN M, 1997, CANCER RES, V57, P3016 AUVINEN M, 1997, J NATL CANCER I, V89, P533 BOYTON AL, 1983, ADV CYCLIC NUCLEOTID, P193 COOK SJ, 1993, SCIENCE, V262, P1069 DEBUSTROS A, 1985, J BIOL CHEM, V260, P98 EDWARDS DR, 1992, EMBO J, V11, P2415 EGAN SE, 1987, MOL CELL BIOL, V7, P830 HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153 HURTA RAR, 1994, J CELL PHYSIOL, V161, P383 HURTA RAR, 1994, J CELL PHYSL, V158, P187 HURTA RAR, 1996, J CELL BIOCHEM, V60, P572 HURTA RAR, 1999, EXPT BIOL, V99 KUBOTA S, 1997, J NATL CANCER I, V89, P567 LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442 MANNI A, 1995, CANCER LETT, V95, P23 MANNI A, 1995, J CELL PHYSIOL, V163, P129 MUKHERJEE R, 1987, J BIOL CHEM, V262, P13697 NISHIZUKA Y, 1988, NATURE, V334, P661 PATEL AR, 1998, AM J PHYSIOL-CELL PH, V275, C590 PEGG AE, 1969, J BIOL CHEM, V244, P682 PEGG AE, 1988, CANCER RES, V48, P759 PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297 PHILLIPS DR, 1986, BIOCHEMISTRY-US, V25, P7355 ROGER PP, 1995, VITAM HORMON, V51, P159 SCHWARZ LC, 1988, CANCER RES, V48, P6999 SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305 TABIB A, 1998, INT J BIOCHEM CELL B, V30, P135 TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749 WANG JY, 1992, AM J PHYSIOL, G494 WITHERS DJ, 1997, CLIN SCI, V92, P445 WRIGHT JA, 1990, BIOCH CELL BIOL, V68, P1364 WRIGHT JA, 1993, CRIT REV ONCOGENESIS, V4, P473; NR: 34; TC: 0; J9: J CELL BIOCHEM; SU: Suppl. 36; PG: 13; GA: 429XN
Source type: Electronic(1)
Language
- English
Subjects
- cAMP
- Beta
- malignant progression
- ORNITHINE-DECARBOXYLASE
- ACTIVATION
- H-ras
- POLYAMINES
- inhibition
- RIBONUCLEOTIDE REDUCTASE
- MECHANISMS
- Cell Biology
- FIBROBLAST GROWTH-FACTOR
- S-adenosylmethionine decarboxylase
- TRANSCRIPTION
- Biochemistry & Molecular Biology
- PROTEIN-KINASE